Table 2.
Species in culture-positive, PCR-positive speciesa | n | (%) | Species in culture-positive, PCR-negative speciesb | n | (%) | Species in culture-negative, PCR-positive speciesb | n | (%) |
---|---|---|---|---|---|---|---|---|
Candida sp. | 10 | (45) | Candida sp | 8 | (20) | Staphylococcus epidermidis | 21 | (30) |
Staphylococcus epidermidis | 5 | (23) | Enterococcus spp. | 6 | (15) | Streptococcus spp. | 9 | (13) |
Streptococcus spp. | 2 | (9) | Propionibacterium acnes | 5 | (12) | Enterobacter spp. | 4 | (6) |
Enterobacter spp. | 1 | (5) | Staphylococcus epidermidis | 5 | (12) | Corynebacterium spp. | 4 | (6) |
Propionibacterium acnes | 1 | (5) | Enterobacter spp. | 2 | (5) | Klebsiella spp. | 4 | (6) |
Pseudomonas aeruginosa | 1 | (5) | Eikenella corrodens | 2 | (5) | Citrobacter freundii | 3 | (4) |
Streptococcus spp. | 1 | (5) | Escherichia coli | 2 | (5) | Pseudomonas aeruginosa | 3 | (4) |
Mycoplasma hominis | 1 | (5) | Klebsiella spp. | 2 | (5) | Salmonella enterica | 3 | (4) |
Aspergillus fumigatus | 1 | (3) | Proteus mirabilis | 2 | (3) | |||
Bacteroides fragilis | 1 | (3) | Raoutella spp. | 2 | (3) | |||
Corynebacterium spp. | 1 | (3) | Bacteriodes xylanisolvens | 1 | (1) | |||
Finegoldia magna | 1 | (3) | Dialister invisus | 1 | (1) | |||
Mycobacterium chimaera | 1 | (3) | Escherichia coli | 1 | (1) | |||
Pseudomonas aeruginosa | 1 | (3) | Escherichia fergusonii | 1 | (1) | |||
Staphylococcus spp. | 1 | (3) | Fusobacterium nucleatum | 1 | (1) | |||
Streptococcus spp. | 1 | (3) | Listeria innocua | 1 | (1) | |||
Mycobacterium intracellulare | 1 | (1) | ||||||
Pasteurella multocida | 1 | (1) | ||||||
Pluralibacter pyrinus | 1 | (1) | ||||||
Propionibacterium acnes | 1 | (1) | ||||||
Shigella spp. | 1 | (1) | ||||||
Yokenella spp. | 1 | (1) | ||||||
Polymicrobial | 2 | (3) | ||||||
Total | 22 | (100) | Total | 40 | (100) | Total | 69 | (100) |
Sample origin: vascular prosthesis (5%), deep wound cultures (80%), superficial wound culture (5%), negative pressure wound therapy foams (10%);
Sample origin: vascular prosthesis (12%), deep wound cultures (78%), superficial wound cultures (10%), biopsy (5%); 3Sample origin: vascular prostheses (5%), biopsy (5%), negative pressure wound therapy foams (5%), deep wound cultures (78%), superficial wound cultures (6%).